Novel biopesticide for systemic control of lepidopteran pests

Hi Cell Eradico® is the world's first botanical systemic insecticide with independently validated efficacy comparable to Chlorantraniliprole — the $1.5B annual revenue synthetic gold standard — delivering broad-spectrum pest control without a single synthetic residue. Chlorantraniliprole (Rynaxypyr®) dominates global insecticide markets precisely because of its systemic action and Lepidopteran efficacy. No botanical has previously matched it — until Eradico. Derived from highly refined GRAS-category botanical actives, Eradico achieves true systemic distribution throughout all above-ground plant tissues, delivering both preventive and curative control against Lepidopteran and Hemipteran pests — the two most economically destructive pest orders in global horticulture. Independent CRO validation confirms performance parity with Chlorantraniliprole at recommended field dosages. The global biopesticide market is projected to reach $62B by 2030, growing at 14.5% CAGR — driven by regulatory pressure on synthetic chemistries, retailer clean-label mandates, and grower demand for resistance management tools. Eradico is uniquely positioned to capture this transition: the only botanical that matches the efficacy benchmark the market already trusts, with field-validated yield improvements of up to 35% under commercial conditions. Eradico is at TRL 6, with regulatory and safety validation underway. Hi Cell seeks strategic partners for global commercialisation. The market is moving away from synthetics. Eradico gives it somewhere to go.